Prodromal Symptoms clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
open to eligible people ages 13-25
The present study is a confirmatory efficacy trial of Family Focused Therapy for youth at clinical high risk for psychosis (FFT-CHR). This trial is sponsored by seven mature CHR clinical research programs from the North American Prodrome Longitudinal Study (NAPLS). The young clinical high risk sample (N = 220 youth ages 13-25) is to be followed at 6-month intervals for 18 months.
San Francisco, California and other locations
Our lead scientists for Prodromal Symptoms research studies include Daniel H. Mathalon, Ph.D., M.D. Holly K. Hamilton, Ph.D..